School of Medicine At Mount Sinai Icahn's Net Worth

$427 Million

Estimate Recalculated Feb 7, 2024 03:57PM EST

Who is School of Medicine At Mount Sinai Icahn?

School of Medicine At Mount Sinai Icahn has an estimated net worth of $427 Million. This is based on reported shares across multiple companies, which include GeneDx Holdings Corp., and Renalytix plc.

SEC CIK

School of Medicine At Mount Sinai Icahn's CIK is 0001883139

Past Insider Trading and Trends

2022 was School of Medicine At Mount Sinai Icahn's most active year for acquiring shares with 1 total transactions. School of Medicine At Mount Sinai Icahn's most active month to acquire stocks was the month of December. 2022 saw School of Medicine At Mount Sinai Icahn paying a total of $25,000,000.00 for 6,250,000 shares, this is the most they've acquired in one year.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

GeneDx Holdings Corp. (WGS) Snapshot price: $3.75

Investor

School of Medicine At Mount Sinai Icahn owns 123,176,901 units of Class A Common Stock which is worth $461,913,378.75. From 2021 to 2023 School of Medicine At Mount Sinai Icahn acquired a total of 34,821,428 shares in GeneDx Holdings Corp. at a cost of $34,999,999.80.

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+30.20%
28.57M
$0.35
$9,999,999.80
123.18M
Jan 31
Form 4
+7.07%
6.25M
$4.00
$25,000,000.00
94.61M
Apr 29
Form 3
0
0
No matching records found

Renalytix plc (RNLX) Snapshot price: $0.2687

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 3
0
0
No matching records found